management of osteoporosis in postmenopausal women

NAMS has submitted to AHRQ an updated position statement on the management of osteoporosis in postmenopausal women

Menopause: The Journal of The North American Menopause Society
Vol. 17, No. 1, pp. 23/24
DOI: 10.1097/gme.0b013e3181cdd4a7
* 2010 by The North American Menopause Society


NAMS continuing medical education activity
Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society
This position statement, which begins on page 25, has been designated a continuing medical education (CME) activity from The North American Menopause Society (NAMS).

GOAL
To demonstrate an increase in, or affirmation of, current knowledge regarding the management of osteoporosis in postmenopausal women.

LEARNING OBJECTIVES
After reading this position statement, participants should be able to:
& Describe the effect of menopause and aging on bone health.
& Identify risk factors that contribute to fracture risk.
& Discuss the assessments of risk factors for fracture and how to rule out secondary causes of osteoporosis.
& Identify nonpharmacologic and lifestyle approaches to prevent bone loss and fractures.
& Review the effects of various therapeutic agents on preventing osteoporotic fracture; understand their effects on bone density and turnover.
& Develop individual treatment strategies to reduce morbidity and improve quality of life based on results of clinical trials.
& Understand the clinical effects of discontinuing different antiresorptive and anabolic therapies.

TARGET AUDIENCE
This educational activity has been developed to meet the educational needs of healthcare professionals who provide care to postmenopausal women.

ACCREDITATION
The North American Menopause Society (NAMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NAMS designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)i.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS
Program participants should complete the CME selfassessment examination provided on page 55.

COMMERCIAL SUPPORT
The CME activity is supported by an unrestricted educational grant from the Alliance for Better Bone Health, a collaboration between Warner Chilcott plc and its affiliates and sanofi-aventis (US).

ACKNOWLEDGMENTS
NAMS appreciates the contributions of the following members of the Osteoporosis Editorial Board: Sydney L. Bonnick, MD, FACP, Medical Director, Clinical Research Center of North Texas, Adjunct Professor, Departments of Biology and Kinesiology, University of North Texas, Denton, TX; Steven T. Harris, MD, FACP, Clinical
Professor of Medicine, University of California, San Francisco, San Francisco, CA; David L. Kendler, MD, FRCPC, Associate Professor of Medicine, University of British Columbia, Vancouver, BC, Canada; Michael R. McClung, MD, Director, Oregon Osteoporosis Center, Portland, OR; and Stuart L. Silverman, MD, FACP, FACR,
Attending Physician, Cedars-Sinai Medical Center, Clinical Professor of Medicine and Rheumatology, David Geffen School of Medicine, University of California at Los Angeles, Medical Director, Osteoporosis Medical Center Clinical Research Center, Beverly Hills, CA.

The position statement was reviewed and approved by the 2008-2009 NAMS Board of Trustees: JoAnn V. Pinkerton, MD, NCMP (President), Professor of Obstetrics and Gynecology, Vice Chair for Academic Affairs, Director, Midlife Health, University of Virginia Health Sciences Center, Charlottesville, VA; Cynthia A. Stuenkel,
MD, NCMP (President-Elect), Clinical Professor of Medicine, University of California, San Diego, La Jolla, CA; Steven R. Goldstein, MD, NCMP (Treasurer), Professor of Obstetrics and Gynecology, New York University School of Medicine, New York, NY; Thomas B. Clarkson, DVM (Secretary), Professor of Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC; Elizabeth Contestabile, RN, BScN, NCMP, Nurse Educator, Shirley E. Greenberg Women_s Health Centre, The Ottawa Hospital, Riverside Campus, Ottawa, ON, Canada; Robert R.
Freedman, PhD, Professor, Departments of Psychiatry and Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI; Victor W. Henderson, MD, MS, NCMP, Professor, Departments of Health Research & Policy and of Neurology &
Neurological Sciences, Stanford University School of Medicine, Stanford, CA; Risa Kagan, MD, FACOG, CCD, NCMP, Clinical Professor, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, East Bay Physicians Medical Group, Berkeley, CA; JoAnn E. Manson, MD, DrPH, Professor of Medicine and the Elizabeth Fay Brigham Professor of Women_s Health, Harvard Medical School, Chief of Preventive Medicine and Co-Director, Connors Center for Women’s Health and Gender Biology, Brigham and Women_s Hospital, Boston, MA; Diane T. Pace, PhD, FNP-BC, CCD, FAANP, NCMP, Assistant Dean for Faculty Practice, Director, Center for Health Evaluation and Lifestyle Promotion, University of Tennessee Health Science Center, Memphis, TN; Jan L. Shifren, MD, NCMP, Associate Professor of
Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Director, Menopause Program, Vincent Obstetrics and Menopause, Vol. 17, No. 1, 2010 23

abrir aquí para acceder al documento NGC AHRQ completo: pdf de 34 páginas -
http://www.menopause.org/PSosteo10.pdf